Scott Thomas Jackson Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Thomas Jackson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Thomas Jackson. Scott Thomas Jackson is a Director in GLYCOMIMETICS INC ($GLYC) and a Director in MACROGENICS INC ($MGNX) and an Chief Executive Officer in Celator Pharmaceuticals Inc ($CPXX) and a Director in Spero Therapeutics, Inc. ($SPRO).
Address: 303B COLLEGE ROAD EAST PRINCETON 08540 NJ
Companies in which Scott Thomas Jackson is an Insider
Celator Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Thomas Jackson: Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Jul 12 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GLYCOMIMETICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Thomas Jackson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 21 2019
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MACROGENICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Thomas Jackson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 17 2021
$MGNX Market Capitalization: $637.48M
$MGNX Previous Close: $18.63
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Spero Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Thomas Jackson: Director
Holdings: 0 shares
Latest Transaction: Oct 27 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Scott Thomas Jackson
Sentiment: All, CPXX, GLYC, MGNX, SPRO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17 2021 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 28.88 | 15,000 | 433,200 | 15,000 | |
| Oct 27 2020 | SPRO | Spero Therapeutics ... | Jackson Scott Thomas | Director | Option Exercise | A | 13.52 | 7,500 | 101,400 | 7,500 | |
| Jun 23 2020 | SPRO | Spero Therapeutics ... | Jackson Scott Thomas | Director | Option Exercise | A | 13.94 | 15,000 | 209,100 | 15,000 | |
| May 15 2020 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 24.97 | 15,000 | 374,550 | 15,000 | |
| May 21 2019 | GLYC | GLYCOMIMETICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 12.39 | 21,000 | 260,190 | 21,000 | |
| May 20 2019 | MGNX | MACROGENICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 18.00 | 10,000 | 180,000 | 10,000 | |
| Nov 28 2018 | GLYC | GLYCOMIMETICS INC | Jackson Scott Thomas | Director | Option Exercise | A | 11.52 | 22,000 | 253,440 | 22,000 |